Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
23,173,297
-
Share change
-
+10,243,301
-
Total reported value
-
$1,123,137,433
-
Price per share
-
$48.47
-
Number of holders
-
79
-
Value change
-
+$496,891,577
-
Number of buys
-
53
-
Number of sells
-
24
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2021
As of 31 Mar 2021,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,173,297 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., Cederberg Capital Ltd, Ward Ferry Management (BVI) Ltd, Avidity Partners Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Artisan Partners Limited Partnership, Artal Group S.A., MANUFACTURERS LIFE INSURANCE COMPANY, THE, PRICE T ROWE ASSOCIATES INC /MD/, and Octagon Capital Advisors LP.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.